Company / Assets per Share
Crinetics Pharmaceuticals, Inc. Assets per Share History
FY2017-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Assets per Share
$11.78
FY2025
5-year range
$6.54 / $15.44
FY2021-FY2025
Trend
-23.7%
vs FY2024
Sector context
#83 of 210
Health Care
What the data says
At $11.78, Crinetics Pharmaceuticals, Inc.'s assets per share ranks #83 of 210 in the Health Care sector. Assets per Share has fluctuated over the past 9 years, ranging from $6.54 in FY2022 to $5418.60 in FY2019.
Based on SEC 10-K filings.
11.78 in FY2025 with a 5-year CAGR of +9.3%.
Improved from $10.94 to $11.78 over the past 2 years.
Health Care sector context is included.
Assets per Share over time
Growth rates
- 3-Year CAGR
- +21.7%
- 5-Year CAGR
- +9.3%
- 10-Year CAGR
- -
Sector benchmark
#83 of 210 in Health CareTop 40% of 210This company $11.78 Sector average $353.15
▼
-96.7% below sector average
Key checks
Key Insights
- In FY2025, assets per share decreased 23.7% year-over-year.
- Ranks #83 out of 210 companies in the Health Care sector.
- Peak assets per share was recorded in FY2019.
- Lowest assets per share in the period was in FY2022.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Assets per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $11.78 | -23.7% |
| FY2024 | $15.44 | +41.1% |
| FY2023 | $10.94 | +67.4% |
| FY2022 | $6.54 | -11.4% |
| FY2021 | $7.37 | -2.5% |
| FY2020 | $7.56 | -99.9% |
| FY2019 | $5418.60 | +4798.4% |
| FY2018 | $110.62 | +872.3% |
| FY2017 | $11.38 | - |
| FY2016 | - | - |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026